Agenus | AGEN - Trade Creditors


Agenus reported $58.98M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Agenus USD 58.98M 12.1M Jun/2026
Amgen USD 2.86B 16.65B Jun/2026
AstraZeneca USD 22.89B 388M Jun/2026
Bristol-Myers Squibb USD 4.16B 76M Jun/2026
Celldex Therapeutics USD 14.68M 4.32M Jun/2026
CSL USD 3.17B 290M Dec/2025
Eli Lilly USD 6.11B 1.08B Jun/2026
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 7M Jun/2026
Glaxosmithkline GBP 14.34B 6.39B Mar/2026
Incyte USD 1.39B 1.16B Jun/2026
Intrexon USD 4.85M 3.12M Jun/2024
J&J USD 9.22B 1.24B Jun/2026
Jiangsu Hengrui CNY 2.33B 64.06M Mar/2026
Karyopharm Therapeutics USD 4.28M 276K Mar/2026
MacroGenics USD 3.44M 845K Jun/2026
Merck EUR 2.07B 61M Jun/2026
Merck USD 3.83B 36M Jun/2026
Northwest Biotherapeutics 31.58M 5.13M Mar/2026
Novartis USD 4.26B 64M Jun/2026
Novavax USD 22.94M 6.84M Jun/2026
Pfizer USD 4.58B 75M Jun/2026
Regeneron Pharmaceuticals USD 1.16B 132.2M Jun/2026
Rigel Pharmaceuticals USD 3.85M 3.44M Sep/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Veracyte USD 8.02M 1.12M Jun/2026